🇺🇸 Lidocaine (Zingo) in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Lidocaine (Zingo) on 16 August 2007

Marketing authorisation

FDA — authorised 16 August 2007

Application: NDA022114
Marketing authorisation holder: POWDER PHARMS
Local brand name: ZINGO
Indication: SYSTEM — INTRADERMAL
Status: approved

Read official source →

Other Anesthesia / Pain Management approved in United States

Frequently asked questions

Is Lidocaine (Zingo) approved in United States?

Yes. FDA authorised it on 16 August 2007.

Who is the marketing authorisation holder for Lidocaine (Zingo) in United States?

POWDER PHARMS holds the US marketing authorisation.